Arab Pharmaceuticals (ADCI) Financial Statements
Annual financial statement highlights for Arab Pharmaceuticals, in Egyptian pounds (EGP) covering fiscal years 2006–2025. Figures are updated weekly from EGX filings via TradingView.
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Total assets | Total debt | DPS |
|---|---|---|---|---|---|---|---|
| 2025 | 1.12B | 198.93M | 16.5779 | -64.04M | 1.32B | 512.16M | 8.333 |
| 2024 | 785.52M | 88.35M | 7.3621 | -145.48M | 1.13B | 517.09M | 4.175 |
| 2023 | 633.73M | 71.13M | 5.9271 | 23.6M | 682.07M | 192.07M | 2.25 |
| 2022 | 505.04M | 76.3M | 6.3583 | -56.79M | 573.98M | 151.07M | 2.40 |
| 2021 | 537.05M | 101.41M | 8.4509 | 11.95M | 446.27M | 21.21M | 2.50 |
| 2020 | 520.8M | 92.8M | 7.7333 | 72.54M | 371.83M | 14M | 2.00 |
| 2019 | 436.35M | 43.1M | 3.5919 | 31.04M | 298.59M | 18.49M | 1.90 |
| 2018 | 382.93M | 39.47M | 3.2889 | 22.09M | 274.69M | 12.29M | 1.50 |
| 2017 | 339.03M | 35.12M | 2.925 | 38.59M | 261.13M | 7.45M | 1.00 |
| 2016 | 250.17M | 14.45M | 1.205 | 11.72M | 187.08M | 21.03M | 0.675 |
| 2015 | 223.49M | 4.68M | 0.39 | -23.89M | 177.37M | 25.11M | 0.075 |
| 2014 | 206.12M | 2.81M | 0.345 | -141,550 | 190.01M | 22.84M | 0.05 |
| 2013 | 172.23M | 319,801.1 | 0.04 | 12.04M | 187.21M | 18.66M | 0.00 |
| 2012 | 181.08M | 4.16M | 0.515 | -21.34M | 201.61M | 54.36M | 0.35 |
| 2010 | 155.34M | 7.87M | 0.9733 | 15.2M | 157.84M | 0 | 0.00 |
| 2009 | 142.45M | 12.89M | — | -982,760 | 153.78M | 0 | 1.1333 |
| 2008 | 151.82M | 17.7M | — | 3.73M | 144.1M | 0 | 0.3889 |
| 2007 | 146.49M | 20.22M | — | 22.32M | 137.96M | 369.55 | 1.50 |
| 2006 | 149.94M | 19.88M | — | 20.12M | 150.7M | 218.51 | 0.8889 |
All figures in EGP. Source: company disclosures to the Egyptian Exchange via TradingView; updated weekly.